Corning Showcases Solutions for Cancer Research at AACR 2016

We use cookies to ensure the best experience on our website.
View Cookie Policy
Accept Cookie Policy
Change My Settings
Required for the site to function.
Augment your site experience.
Lets Corning work with partners to enable social features and marketing messages.

This site is best viewed in a modern web browser. Please update your browser for the best experience possible.

Corning Showcases Solutions for Cancer Research at AACR 2016

Corning Showcases Solutions for Cancer Research at AACR 2016

Solutions for Cancer Research at AACR 2016

News Releases
Corporate Communications
Corning Showcases Solutions for Cancer Research at AACR 2016
Corning Showcases Solutions for Cancer Research at AACR 2016
CORNING, N.Y. | Corning Incorporated | April 13, 2016
Highlights include tools for 3D cell culture

Corning Incorporated (NYSE: GLW) will showcase its latest solutions for cancer research, including tools for 3D cell culture, in exhibit 330 at the American Association for Cancer Research (AACR) 2016 annual meeting, April 16-20 in New Orleans, Louisiana.

Featured innovations and laboratory solutions include:

  • Corning® Matrigel® matrix
  • Corning spheroid microplates
  • Transwell® permeable supports
  • Corning CoolCell®, CoolBox™ and CoolRack® systems

“Recent advancements in 3D cell culture models have accelerated translational research in cancer cell biology, tissue engineering, and regenerative medicine,” said Richard Eglen, Ph.D., vice president and general manager, Corning Life Sciences. “We believe this is a game changer in the field and a significant step forward in the fight against cancer.”

Additionally, SelectScience will announce the winner of its Scientists’ Choice Award for Best New Life Sciences Product of the Year at the AACR annual meeting. Corning® HepatoCells have been nominated for this accolade. Corning HepatoCells are a robust, consistent, and convenient alternative to primary human hepatocytes.

“We are continuously working on solutions to help our customers decipher the intricacies of cancer,” said Keith R. Olson, Ph.D., director, business operations, Corning Life Sciences. “We are committed to delivering quality products, innovations, and scientific support that stand out in our industry and help researchers achieve their goals.”

Corning Matrigel Matrix is the original, trusted extracellular matrix (ECM). Used for 2D and 3D cell culture, the matrix enables improved attachment and differentiation of both normal and transformed anchorage-dependent cell types. Additionally, the matrix better mimics in vivo environments for 2D and 3D cell culture applications.

Corning’s spheroid microplates are ideal for generating and analyzing 3D spheroids in the same microplate. Featuring Corning’s Ultra-Low Attachment surface, the microplates enable uniform and reproducible spheroid formation which is well suited for cancer research centers studying tumor formation and cancer invasion.

Transwell permeable supports are an essential tool to study cancer progression. These cell culture inserts create in vivo-like conditions critical to study angiogenesis, tumor invasion, migration, and other complex cell interactions and functions that promote tumor growth.

Corning’s innovative storage, heating, and cooling solutions include the Corning CoolCell alcohol-free cryogenic freezing container, Corning CoolRack thermo-conductive modules, and the Corning CoolBox cooling systems. These reusable, flexible platforms provide consistent temperature control and help reduce variability.

Corning Life Sciences continues to bring new and innovative laboratory technologies to researchers worldwide and help customers succeed by providing novel, high-quality products and services in cell culture, bioprocessing, drug discovery and development, genomics, and microbiology.

To learn more about Corning Life Sciences products, please contact a customer service representative at 1-800-492-1110, toll free in the United States; (+1) 1-978-442-2200 internationally; or visit

Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

Digital Media Disclosure
In accordance with guidance provided by the SEC regarding the use of company websites and social media channels to disclose material information, Corning Incorporated (“Corning”) wishes to notify investors, media, and other interested parties that it intends to use its website ( to publish important information about the company, including information that may be deemed material to investors. The list of websites and social media channels that the company uses may be updated on Corning’s media and website from time to time. Corning encourages investors, media, and other interested parties to review the information Corning may publish through its website and social media channels as described above, in addition to the company’s SEC filings, press releases, conference calls, and webcasts.

About Corning Incorporated
Corning ( is one of the world’s leading innovators in materials science. For more than 160 years, Corning has applied its unparalleled expertise in specialty glass, ceramics, and optical physics to develop products that have created new industries and transformed people’s lives. Corning succeeds through sustained investment in R&D, a unique combination of material and process innovation, and close collaboration with customers to solve tough technology challenges. Corning’s businesses and markets are constantly evolving. Today, Corning’s products enable diverse industries such as consumer electronics, telecommunications, transportation, and life sciences. They include damage-resistant cover glass for smartphones and tablets; precision glass for advanced displays; optical fiber, wireless technologies, and connectivity solutions for high-speed communications networks; trusted products that accelerate drug discovery and manufacturing; and emissions-control products for cars, trucks, and off-road vehicles.